Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Phytother Res ; 23(8): 1066-74, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19172579

ABSTRACT

Polyphenolic extracts of the principal flavonoid classes present in cranberry were screened in vitro for cytotoxicity against solid tumor cells lines, identifying two fractions composed principally of proanthocyanidins (PACs) with potential anticancer activity. Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF-MS) analysis of the proanthocyanidins (PACs) fractions indicated the presence of A-type PACs with 1-4 linkages containing between 2-8 epicatechin units with a maximum of 1 epigallocatechin unit. PACs exhibited in vitro cytotoxicity against platinum-resistant human ovarian, neuroblastoma and prostate cancer cell lines (IC50 = 79-479 microg/mL) but were non-cytotoxic to lung fibroblast cells (IC50 > 1000 microg/ml). SKOV-3 ovarian cancer cells treated with PACs exhibited classic apoptotic changes. PACs acted synergistically with paraplatin in SKOV-3 cells. Pretreatment of SKOV-3 cells with PACs (106 microg/ml) resulted in a significant reduction of the paraplatin IC50 value. Similarly, in a BrdU incorporation assay, co-treatment of SKOV-3 cells with PACs and paraplatin revealed reduced cell proliferation at lower concentrations than with either individually. In SKOV-3 cell cultures co-treated with PAC-1 and paraplatin, an HPLC analysis indicated differential quantitative presence of various PAC oligomers such as DP-8, -9, -11 and -14 indicating either selective binding or uptake. Cranberry proanthocyanidins exhibit cell-line specific cytotoxicity, induce apoptotic markers and augment cytotoxicity of paraplatin in platinum-resistant SKOV-3 ovarian cancer cells.


Subject(s)
Carboplatin/pharmacology , Plant Extracts/pharmacology , Proanthocyanidins/pharmacology , Vaccinium macrocarpon/chemistry , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Female , Flavonoids/isolation & purification , Flavonoids/pharmacology , Humans , Ovarian Neoplasms/drug therapy , Phenols/isolation & purification , Phenols/pharmacology , Polyphenols , Proanthocyanidins/isolation & purification , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2.
Gynecol Oncol ; 103(1): 261-70, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16624391

ABSTRACT

OBJECTIVE: Epithelial ovarian cancer has the highest mortality rate among gynecologic cancers. Chemotherapy is an essential component of its treatment. While isothiocyanates are known to possess chemopreventive effects against various cancers, yet little is known about their chemotherapeutic potential in ovarian cancer (OC). In the present study, we examined the antiproliferative and apoptotic effect of phenethyl isothiocyanate (PEITC), a naturally occurring isothiocyanate on OVCAR-3 cells. METHODS: Cytotoxic activity of PEITC on OVCAR-3 cells was determined using cell proliferation, apoptosis (DNA fragmentation and TUNEL assay) and caspase-activation studies. The role of PARP-1, Bax, and Bcl-2 in apoptosis was analyzed by Western blotting. Activation of JNK1/2, p38, Akt, ERK1/2, and c-Myc was examined by immunoblotting. Specific inhibitors of caspases, JNK1/2, p38, and MEK were used to corroborate these data. RESULTS: PEITC was cytotoxic to OVCAR-3 cells, and inhibited proliferation in a dose-dependent fashion (IC(50) = 23.2 microM). PEITC induced apoptosis by activating caspase-3 and -9, without capsase-8 activation. Anti-apoptotic Bcl-2 levels were suppressed while pro-apoptotic Bax levels were enhanced. PEITC suppressed activation of Akt, ERK1/2, and the expression of transcription factor c-Myc, while simultaneously activating pro-apoptotic p38 and JNK1/2. Specific inhibitors of caspase-3 and -9, JNK1/2, and p38 reversed the cytotoxic effect of PEITC. CONCLUSIONS: These findings demonstrate that PEITC exhibits cytotoxicity towards OVCAR-3 cells and induces apoptosis via caspase-9 and -3 pathways. PEITC inhibits Akt, ERK1/2 survival signaling, and c-Myc while simultaneously activating pro-apoptotic p38 and JNK1/2. Systematic preclinical and clinical trials with PEITC in ovarian cancer are indicated.


Subject(s)
Apoptosis/drug effects , Caspases/metabolism , Isothiocyanates/pharmacology , Mitogen-Activated Protein Kinases/metabolism , Apoptosis/physiology , Caspase 3 , Caspase 9 , Caspase Inhibitors , Cell Growth Processes/drug effects , Cell Line, Tumor , Enzyme Activation/drug effects , Female , Humans , MAP Kinase Kinase 4/metabolism , MAP Kinase Signaling System/drug effects , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/enzymology , Ovarian Neoplasms/pathology , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , bcl-2-Associated X Protein/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism
3.
Indian J Exp Biol ; 39(7): 668-72, 2001 Jul.
Article in English | MEDLINE | ID: mdl-12019760

ABSTRACT

EHb-a herbo-mineral formulations of iron (ferrous form) produced a significantly higher and dose dependent increase in the haemoglobin level, as compared to Fefol (a non-complex-chelated iron preparation). Also, EHb did not produce any overt toxicity or gastric irritation at these dose levels. The results suggest that EHb can be of a better choice in the treatment of anaemia than any other commercially available chelated iron preparations.


Subject(s)
Anemia/drug therapy , Iron, Dietary/therapeutic use , Phytotherapy , Plant Preparations/therapeutic use , Anemia/blood , Animals , Female , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Hemoglobins/metabolism , Iron Chelating Agents/therapeutic use , Iron Chelating Agents/toxicity , Iron, Dietary/toxicity , Male , Plant Preparations/toxicity , Rats
4.
Indian J Exp Biol ; 37(1): 17-22, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10355360

ABSTRACT

Effects of pre- and post-natal undernutrition on learning and memory parameters were studied in albino rats. Prenatal undernutrition was induced in rat pups by restricting the mother's diet by 50% during the entire gestation period, whereas postnatal undernutrition was induced in rat pups by restriction of their diet by rotating them between lactating and non-lactating maternalised females for 12 hr each day during suckling period from 2nd day to 18th day after birth. At 2.5 to 3 months of age all the rat offsprings were subjected to (i) original and reversal discrimination learning, (ii) passive avoidance, and (iii) active avoidance and its retention tests. The results indicate that both pre- and post-natal undernutrition in rat pups caused significant deficits in original and reversal discrimination learning, retention of passive avoidance after one week retention interval, and retention of active of avoidance learning. However, both pre- and post-natal undernutrition did not show significant effect on acquisition of active avoidance and retention of passive avoidance after 24 hr retention interval.


Subject(s)
Learning , Memory , Nutrition Disorders/physiopathology , Pregnancy, Animal , Animals , Behavior, Animal , Body Weight , Female , Male , Pregnancy , Rats
5.
Indian J Exp Biol ; 37(2): 117-23, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10641129

ABSTRACT

Rodent models of clinical depression are extensively used for the evaluation of putative antidepressants. In the present review, the available experimental methods which can be utilized by most laboratories involved in preclinical screening of antidepressants, have been discussed. The methods have been categorized on the basis of induction of the depressive state or on the assumption that monoamine deficiency leads to depression. These methods have been critically validated in terms of efficacy of standard antidepressants in these tests and, in some cases, by the neurochemical basis of depression, namely, the deficient monoaminergic theory of clinical depression.


Subject(s)
Antidepressive Agents/pharmacology , Animals , Behavior, Animal/drug effects , Depression/chemically induced , Depression/drug therapy , Depression/etiology , Disease Models, Animal , Drug Evaluation, Preclinical/methods , Female , Humans , Male , Mice , Rats
6.
Psychopharmacology (Berl) ; 136(2): 148-52, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9551771

ABSTRACT

Ginkgolic acid conjugates (GAC) (6-alkylsalicylates, namely n-tridecyl-, n-pentadecyl-, n-heptadecyl-, n-pentadecenyl- and n-heptadecenylsalicylates) isolated from the leaves of Indian Ginkgo biloba Linn., (IGb) were tested for their putative role in anxiety in rats. Elevated plus maze, open-field behaviour, novelty-induced feeding latency and social interaction were the rodent behavioural models used in this study. GAC (0.3 and 0.6 mg/kg, each, p.o.) on single acute administration, showed dose-related changes in the behaviour. GAC (0.6 mg/kg) and DZ augmented open arm entries, the open arm/closed arm entries ratio and increased time spent in the open arm on the elevated plus maze. In the open field, GAC (0.6 mg/kg) and DZ significantly increased ambulation and reduced the immobility time. EGb 761 showed a similar profile. GAC (0.6 mg/kg) and DZ significantly attenuated the increased latency to feed in novel environment. By contrast, EGb 761 and Ginkocer further augmented feeding latency. None of the drugs tested showed any significant effect in the social interaction test. GAC showed consistent and significant anxiolytic activity in all the variables investigated. By contrast, EGb 761 and Ginkocer, which are devoid of GAC, did not evoke significant activity. However, increased rearing and decreased immobility time only in open field behaviour shown by EGb 761 may be due to some antianxiety activity of a lesser degree. Our observations suggest that GAC may be the active constituents of Ginkgo biloba responsible for the anxiolytic activity.


Subject(s)
Anti-Anxiety Agents/pharmacology , Behavior, Animal/drug effects , Plants, Medicinal , Salicylates/pharmacology , Animals , Diazepam/pharmacology , Female , Flavonoids/pharmacology , Ginkgo biloba , India , Male , Plant Extracts/pharmacology , Rats
7.
Indian J Exp Biol ; 35(6): 565-75, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9357158

ABSTRACT

Rodent models of clinical anxiety are extensively used for evaluating putative anxiolytic activity. In the present review, the available methods which can be utilized by most laboratories, have been discussed. These methods have been categorized as methods involving conditioning techniques and those not involving conditioning. In most cases, the methodology has been briefly discussed in terms of experimental use and efficacy of benzodiazepine and the newer non-benzodiazepine anxiolytics.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Animals , Disease Models, Animal , Evaluation Studies as Topic , Mice , Rats
8.
Indian J Exp Biol ; 35(3): 236-9, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9332168

ABSTRACT

Antioxidant activity of active principles of Withania somnifera, consisting of equimolar concentrations of sitoindosides VII-X and withaferin A, was investigated for their effects on rat brain frontal cortical and striatal concentrations of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX). Results were compared with effects induced by deprenyl, an agent with well documented antioxidant activity. Active glycowithanolides of W. somnifera (WSG) (10 and 20 mg/kg, i.p.), administered once daily for 21 days, induced a dose-related increase in SOD, CAT and GPX activity in frontal cortex and striatum, which was statistically significant on days 14 and 21, except with the lower dose of WSG on GPX activity, where the effect was evident only on day 21. The data were comparable to those induced by deprenyl (2 mg/kg/day, i.p.) with respect to SOD, CAT and GPX activities, which were evident by day 14. These findings are consistent with the therapeutic use of W. somnifera as an Ayurvedic rasayana and medhyarasayana. Antioxidant effect of active principles of W. somnifera may explain, at least in part, the reported antistress, immunomodulatory, cognition-facilitating, anti-inflammatory and anti-aging effects produced by them in experimental animals, and in clinical situations.


Subject(s)
Antioxidants/pharmacology , Plant Extracts/pharmacology , Plants, Medicinal/chemistry , Animals , Brain/drug effects , Ergosterol/analogs & derivatives , Ergosterol/pharmacology , Male , Rats , Rats, Wistar , Sitosterols/pharmacology , Withanolides
9.
Indian J Exp Biol ; 35(3): 297-9, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9332177

ABSTRACT

Diabetes mellitus was induced in male CF strain rats by streptozotocin (STZ) and hyperglycaemia and superoxide dismutase (SOD) activity of pancreatic islet cells was assessed on days 7, 14, 21 and 28. STZ induced significant hyperglycaemia and a concomitant decrease in islet cell SOD activity. Transina (TR), an Ayurvedic herbal formulation comprising of Withania somnifera, Tinospora cordifolia, Eclipta alba, Ocimum sanctum, Picrorrhiza kurroa and shilajit, had little per se effect on blood sugar concentrations and islet SOD activity in euglycaemic rats, in the doses of 100 and 200 mg/kg, p.o. administered once daily for 28 days. However, these doses of TR induced a dose- related decrease in STZ hyperglycaemia and attenuation of STZ induced decrease in islet SOD activity. The results indicate that the earlier reported anti-hyperglycaemic effect of TR may be due to pancreatic islet free radical scavenging activity, the hyperglycaemic activity of STZ being the consequence of decrease in islet SOD activity leading to the accumulation of degenerative oxidative free radicals in islet beta-cells.


Subject(s)
Hyperglycemia/drug therapy , Islets of Langerhans/drug effects , Medicine, Ayurvedic , Phytotherapy , Superoxide Dismutase/drug effects , Animals , Hyperglycemia/enzymology , Islets of Langerhans/enzymology , Male , Rats , Superoxide Dismutase/metabolism
10.
J Psychopharmacol ; 11(3): 219-24, 1997.
Article in English | MEDLINE | ID: mdl-9305413

ABSTRACT

The anxiogenic action of caffeine (10, 25 and 50 mg/kg, i.p.) was investigated in rats and compared with that of yohimbine (2 mg/kg, i.p.). The experimental methods used were the open-field, elevated plus-maze, social interaction and novelty-suppressed feeding latency tests. Caffeine produced a dose-related profile of behavioural changes, which were qualitatively similar to those induced by yohimbine and which indicate an anxiogenic activity in rodents. Thus, both the drugs reduced ambulation and rears, and increased immobility and defaecation in the open-field test. They decreased the number of entries and time spent on the open arms of the elevated-plus maze, reduced social interaction in paired rats and increased the feeding latency in an unfamiliar environment in 48-h food-deprived rats. Lorazepam, a well known benzodiazepine anxiolytic agent, attenuated the anxiogenic effects of caffeine and yohimbine. Subchronic administration of caffeine (50 mg/kg, i.p.) for 21 days, in different groups of animals, induced a significant degree of tolerance in the elevated plus-maze test, which was statistically significant after 14 and 21 days' treatment. Yohimbine, however, did not induce similar tolerance. When caffeine (50 mg/kg, i.p.) was withdrawn after 21 days' administration, to a separate group of rats, significant withdrawal anxiety was observed 48 h later as noted in the elevated plus-maze test. The investigations support clinical evidence of caffeine-induced anxiety, tolerance to anxiety on continued use, and withdrawal anxiety in chronic caffeine-containing beverage users.


Subject(s)
Anxiety/chemically induced , Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , Exploratory Behavior/drug effects , Phosphodiesterase Inhibitors/pharmacology , Animals , Caffeine/antagonists & inhibitors , Drug Tolerance , Male , Rats , Rats, Wistar , Social Behavior , Substance Withdrawal Syndrome , Yohimbine/antagonists & inhibitors , Yohimbine/pharmacology
11.
Indian J Exp Biol ; 34(12): 1216-9, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9246914

ABSTRACT

Effects of pre- and post-natal undernutrition on anxiety and depression paradigms were studied in albino rats. Prenatal undernutrition was induced in rat pups by restricting the dam's daily food during the gestation period whereas postnatal undernutrition in rat pups was induced by rotating them between lactating and non-lactating maternalised females daily for 12 hr during suckling period from 2nd to 18th day after birth. At 2.5 to 3 months of age all the rat pups were subjected to (i) elevated plus maze behaviour, (ii) open-field behaviour, and (iii) swimming induced behavioural despair tests. The results indicate that postnatal undernutrition caused significantly increased anxiety in the elevated plus maze as well as in open-field behaviour tests. Whereas prenatal undernourishment caused lesser degree of anxiogenic behaviours in the elevated plus maze test. Prenatally undernourished rats showed increased anxiety in the open-field behaviour test. Both, pre- and post-natal undernutrition also lead to increased depressive behaviour in the behavioural despair test and postnatal undernourishment caused greater degree of behavioural despair.


Subject(s)
Animal Nutritional Physiological Phenomena , Behavior, Animal , Fetus/physiology , Animals , Anxiety/physiopathology , Depression/physiopathology , Disease Models, Animal , Fasting , Female , Male , Maze Learning , Pregnancy , Rats
12.
Indian J Exp Biol ; 33(8): 576-9, 1995 Aug.
Article in English | MEDLINE | ID: mdl-8543325

ABSTRACT

Isatin (2,3-dioxoindole), one of the components of tribulin, which has been postulated to function as an endogenous marker of stress and anxiety, was shown to induce a dose-related attenuation of learning acquisition in an active avoidance test and inhibition of learning retention, or memory, in a step-down passive avoidance paradigm and transfer latency in an elevated plus-maze, in rats. Earlier studies have indicated that isatin functions as a 5-hydroxytryptamine (5-HT)3 receptor agonist in its anxiogenic activity in rats and is an antagonist at mammalian atrial natriuretic peptide (ANP) receptors. Since 5-HT3 receptor antagonists and centrally administered ANP have been shown to facilitate learning and memory, the observed memory dysfunction induced by isatin can be attributed to its receptor activity at 5-HT3 and ANP receptors. The investigation also indicates that anxiogenic agents are likely to disrupt memory functions.


Subject(s)
Anxiety Disorders/chemically induced , Isatin/toxicity , Memory Disorders/chemically induced , Receptors, Atrial Natriuretic Factor/antagonists & inhibitors , Serotonin Receptor Agonists/toxicity , Animals , Female , Male , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...